Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder

Study published online today in Nature Genetics

2011-08-09

(Press-News.org) August 8th, 2011, Shenzhen, China – BGI, the world's largest genomics organization, Peking University Shenzhen Hospital and Shenzhen Second People's Hospital, announced today that the study on frequent mutations of chromatin remodeling genes in transitional cell carcinoma (TCC) of the bladder was published online in Nature Genetics. This study provides a valuable genetic basis for future studies on TCC, suggesting that aberration of chromatin regulation might be one of the features of bladder cancer.

Bladder cancer is the ninth most common type of cancer worldwide, which affects three times as many men as women. Almost all bladder cancers originate in the urothelium, so they are also known as one of the most common tumors of the genitourinary tract. Each year, about 360,000 new cases of bladder cancer are expected, and about 150,000 people will die of this disease in the world. In North America, South America, Europe, and Asia, TCC is the most common type of bladder cancer diagnosed, accounting for 90% of all bladder malignancies in those regions.

"Considering the high risks of TCC and the lack of comprehensive analysis, we and our partners initiated this project to identify other previously unidentified genes associated with the bladder cancer." said Professor Zhiming Cai, President of Shenzhen Second People's Hospital and the former President of Peking University Shenzhen Hospital. "I hope our unexpected discoveries in this study can provide more important insights into potential diagnoses and the therapeutic applications." he added.

In this study, the exomes of nine patients with TCC were sequenced with BGI's exome sequencing platform. Then, all the somatically mutated genes were screened in a prevalence set of 88 additional patients with TCC at different tumor stages and grades. "After the detections and statistical analysis, we discovered 49 new significantly mutated genes associated with TCC, and these genes are previously unknown to be mutated in TCC." said Professor Yaoting Gui，the co-leading author of the study and Vice-Director of the Institute of Urology at Peking University Shenzhen Hospital, "Another interesting finding is that eight genes among them are associated with chromatin remodeling, which could be related with frequent mutations in the majority of TCCs."

"We identified the genetic aberrations of the chromatin remodeling genes in 59% of the 97 individuals with TCC, and discovered one gene, UTX, could be altered substantially more frequently in tumors with low stages and grades." said Guangwu Guo, one of the co-leading authors of the study and PI of this project at BGI. "This study indicates UTX may pose a potential role in the classification and diagnosis of bladder cancer."

As we all know, aberrations of the chromatin remodeling genes may directly lead to the misregulation of multiple downstream effector genes, consequently promoting the tumor genesis process. "In our study, the newly discovered genetic mutations in the chromatin remodeling genes, except for UTX, are previous unknown in the primary tumors of TCC." said professor Cai. "Our results demonstrate that the disruption of the chromatin remodeling machinery may be one of the main mechanisms that lead to TCC."

Professor Jun Wang, Executive Director of BGI, said, "This study provides further understanding of bladder cancer and other human cancers through the comprehensive analysis of genetic alterations in TCC. It also implicates the necessity to enhance the epigenomics research in the field of cancer studies in the future. "

### About Peking University Shenzhen Hospital Peking University Shenzhen Hospital is a leading academic hospital in Guangdong province of southern China. The hospital covers an area of 67 thousands square meters with construction area of 90 thousands square meters and 925 inpatient beds, and possesses about 1600 staffs, among of whom, there are more than 300 Professors and Associate Professors. The hospital consists of 52 clinical departments including 1 national key department, 1 provincial key department, 5 municipal key departments and laboratories, and 3 hospital key departments. The hospital supplies excellent services for the patients from Shenzhen, Hong Kong and Macao, and also for the patients from other countries all over the World. For more information, please visit www.pkuszh.com.

About BGI BGI was founded in Beijing, China on September 9th, 1999 with the mission of being a premier scientific partner to the global research community. The company's goal is to make leading-edge genomic science highly accessible through its investment in infrastructure that leverages the best available technology, economies of scale, and expert bioinformatics resources. BGI, and its affiliates, BGI Americas and BGI Europe, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications.

BGI has established a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research that has been published to date in more than 50 top-tier academic journals. These accomplishments include sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, most recently, 1000 genomes and human Gut metagenome.

For more information about BGI please visit www.genomics.cn or www.bgisequence.com

Contact Information:

Zhiming Cai,
President of Shenzhen Second People's Hospital.
caizhiming2000@yahoo.com.cn

Bicheng Yang
Director of Global Marketing Department
BGI
+86-755-25273450
yangbicheng@genomics.cn
www.bgisequence.com

ELSE PRESS RELEASES FROM THIS DATE:

How yeast chromosomes avoid the bad breaks

2011-08-09

CAMBRIDGE, Mass. (August 7, 2011) – The human genome is peppered with repeated DNA elements that can vary from a few to thousands of consecutive copies of the same sequence. During meiosis—the cell division that produces sperm and eggs—repetitive elements place the genome at risk for dangerous rearrangements from genome reshuffling. This recombination typically does not occur in repetitive DNA, in part because much of it is assembled into specialized heterochromatin. Other mechanisms that restrain recombination in repetitive DNA have remained elusive, until now. In a ...

Researchers gain new insights into how tumor cells are fed

2011-08-09

Philadelphia, PA, August 8, 2011 – Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies. The results of this study have been published today in the September issue of The American Journal of Pathology. "The central role of capillary sprouting in tumor vascularization makes it an attractive target for anticancer therapy. Our observations suggest, however, ...

Genetic analysis of amniotic fluid shows promise for monitoring fetal development

2011-08-09

Philadelphia, PA, August 8, 2011 – Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology. This analysis could be used to monitor fetal development, enabling clinicians to determine very early in pregnancy whether fetal organ systems are developing normally. The study appears today in the September issue of The Journal of Molecular Diagnostics. Using a previously developed SNAP gene panel as proof of concept, investigators from the Floating Hospital ...

Early morning smokers have increased risk of lung and head and neck cancers

2011-08-09

Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results may help identify smokers who have an especially high risk of developing cancer and would benefit from targeted smoking interventions to reduce their risk. Cigarette smoking increases one's likelihood of developing various types of ...

Technique to stimulate heart cells may lead to light-controlled pacemakers

2011-08-09

A new technique that stimulates heart muscle cells with low-energy light raises the possibility of a future light-controlled pacemaker, researchers reported in Circulation: Arrhythmia & Electrophysiology, a journal of the American Heart Association. "Electronic cardiac pacemakers and defibrillators are well established and successful technologies, but they are not without problems, including the breakage of metal leads, limited battery life and interference from strong magnetic fields," said Emilia Entcheva, Ph.D., senior author of the study and associate professor of ...

Siblings of those with blood clots in leg have higher risk of same disorder

2011-08-09

Siblings of those who have been hospitalized with potentially lethal blood clots in the legs or pelvis are more likely to also suffer the disorder than those with healthy siblings, according to research published in Circulation: Journal of the American Heart Association. The Swedish study is the first to show a direct correlation between venous thromboembolism (VTE) and family risk in a nationwide setting, sorted by age and gender. VTE consists of deep vein thrombosis (DVT), which typically involves blood clots that form in the deep veins of the leg or pelvis, and ...

Light speed hurdle to invisibility cloak overcome by undergraduate

2011-08-09

An undergraduate student has overcome a major hurdle in the development of invisibility cloaks by adding an optical device into their design that not only remains invisible itself, but also has the ability to slow down light. The optical device, known as an 'invisible sphere', would slow down all of the light that approaches a potential cloak, meaning that the light rays would not need to be accelerated around the cloaked objects at great speeds ― a requirement that has limited invisibility cloaks to work only in a specified region of the visible spectrum. This ...

Drug development in the blink of an eye

2011-08-09

The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects. But now, Jeremy Nathans and colleagues, at Johns Hopkins University School of Medicine, Baltimore, have developed a new preclinical approach that they hope can be used alongside current strategies to guide more efficient drug development for brain-related conditions. In the study, ...

JCI online early table of contents: August 8, 2011

2011-08-09

EDITOR'S PICK: Drug development in the blink of an eye The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects. But now, Jeremy Nathans and colleagues, at Johns Hopkins University School of Medicine, Baltimore, have developed a new preclinical approach that they hope can be used alongside current strategies to guide more efficient ...

When and how to toilet train children

2011-08-09

Parents often ask their doctors for advice on toilet training young children, and a new article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110830.pdf summarizes current approaches and evidence to help physicians respond to these queries. "Toilet training is felt to be a natural process that occurs with development, yet very little scientific information is available for physicians who care for children," writes Dr. Darcie Kiddoo, Divisions of Pediatric Surgery and Urology, University of Alberta, Edmonton, ...

Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: